294 related articles for article (PubMed ID: 33452304)
41. Evaluation of Cytotoxicity and Antimicrobial Activity of Experimental Composites Containing Chitosan-Silver Oxide Particles Against Two Main Pathogenic Bacteria in Periodontal Disease.
Nasrabadi N; Ramezanian N; Ghorbanian P; Forouzanfar A; Mohammadipour HS
Protein Pept Lett; 2024; 31(2):97-106. PubMed ID: 37921156
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effects of propolis and essential oils on oral bacteria.
Tambur Z; Miljković-Selimović B; Opačić D; Vuković B; Malešević A; Ivančajić L; Aleksić E
J Infect Dev Ctries; 2021 Jul; 15(7):1027-1031. PubMed ID: 34343129
[TBL] [Abstract][Full Text] [Related]
43. Antimicrobial activity of silver nitrate against periodontal pathogens.
Spacciapoli P; Buxton D; Rothstein D; Friden P
J Periodontal Res; 2001 Apr; 36(2):108-13. PubMed ID: 11327077
[TBL] [Abstract][Full Text] [Related]
44. Antibacterial effect of crude extract and metabolites of Phytolacca americana on pathogens responsible for periodontal inflammatory diseases and dental caries.
Patra JK; Kim ES; Oh K; Kim HJ; Kim Y; Baek KH
BMC Complement Altern Med; 2014 Sep; 14():343. PubMed ID: 25241105
[TBL] [Abstract][Full Text] [Related]
45. Antibacterial activities of natural lichen compounds against Streptococcus gordonii and Porphyromonas gingivalis.
Sweidan A; Chollet-Krugler M; Sauvager A; van de Weghe P; Chokr A; Bonnaure-Mallet M; Tomasi S; Bousarghin L
Fitoterapia; 2017 Sep; 121():164-169. PubMed ID: 28736072
[TBL] [Abstract][Full Text] [Related]
46. Repurposing Toremifene for Treatment of Oral Bacterial Infections.
Gerits E; Defraine V; Vandamme K; De Cremer K; De Brucker K; Thevissen K; Cammue BP; Beullens S; Fauvart M; Verstraeten N; Michiels J
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993858
[TBL] [Abstract][Full Text] [Related]
47. Comparative Study on the Characteristics of Weissella cibaria CMU and Probiotic Strains for Oral Care.
Jang HJ; Kang MS; Yi SH; Hong JY; Hong SP
Molecules; 2016 Dec; 21(12):. PubMed ID: 27999400
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of Oral Pathogens Adhesion to Human Gingival Fibroblasts by Wine Polyphenols Alone and in Combination with an Oral Probiotic.
Esteban-Fernández A; Zorraquín-Peña I; Ferrer MD; Mira A; Bartolomé B; González de Llano D; Moreno-Arribas MV
J Agric Food Chem; 2018 Mar; 66(9):2071-2082. PubMed ID: 29464948
[TBL] [Abstract][Full Text] [Related]
49. Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro.
Söderling EM; Marttinen AM; Haukioja AL
Curr Microbiol; 2011 Feb; 62(2):618-22. PubMed ID: 20835828
[TBL] [Abstract][Full Text] [Related]
50. Antimicrobial Effects of Mastic Extract Against Oral and Periodontal Pathogens.
Koychev S; Dommisch H; Chen H; Pischon N
J Periodontol; 2017 May; 88(5):511-517. PubMed ID: 28067105
[TBL] [Abstract][Full Text] [Related]
51. NOX1/2 activation in human gingival fibroblasts by Fusobacterium nucleatum facilitates attachment of Porphyromonas gingivalis.
Ahn SH; Song JE; Kim S; Cho SH; Lim YK; Kook JK; Kook MS; Lee TH
Arch Microbiol; 2016 Aug; 198(6):573-83. PubMed ID: 27071620
[TBL] [Abstract][Full Text] [Related]
52. Label-free quantitative proteomic analysis of the oral bacteria Fusobacterium nucleatum and Porphyromonas gingivalis to identify protein features relevant in biofilm formation.
Ali Mohammed MM; Pettersen VK; Nerland AH; Wiker HG; Bakken V
Anaerobe; 2021 Dec; 72():102449. PubMed ID: 34543761
[TBL] [Abstract][Full Text] [Related]
53. Antibacterial action of Chlorhexidine/thymol containing varnishes in vitro and in vivo.
Jentsch HF; Eckert FR; Eschrich K; Stratul SI; Kneist S
Int J Dent Hyg; 2014 Aug; 12(3):168-73. PubMed ID: 24738759
[TBL] [Abstract][Full Text] [Related]
54. Antimicrobial Effect of Lactobacillus reuteri on Cariogenic Bacteria Streptococcus gordonii, Streptococcus mutans, and Periodontal Diseases Actinomyces naeslundii and Tannerella forsythia.
Baca-Castañón ML; De la Garza-Ramos MA; Alcázar-Pizaña AG; Grondin Y; Coronado-Mendoza A; Sánchez-Najera RI; Cárdenas-Estrada E; Medina-De la Garza CE; Escamilla-García E
Probiotics Antimicrob Proteins; 2015 Mar; 7(1):1-8. PubMed ID: 25422124
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of malodorous gas formation by oral bacteria with cetylpyridinium and zinc chloride.
Kang JH; Kim DJ; Choi BK; Park JW
Arch Oral Biol; 2017 Dec; 84():133-138. PubMed ID: 28987726
[TBL] [Abstract][Full Text] [Related]
56. Quantitative proteomic analysis of extracellular matrix extracted from mono- and dual-species biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis.
Mohammed MMA; Pettersen VK; Nerland AH; Wiker HG; Bakken V
Anaerobe; 2017 Apr; 44():133-142. PubMed ID: 28285095
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of a mouthwash containing ε-poly-L-lysine, funme peptides and domiphen in reducing halitosis and supragingival plaque: a randomized clinical trial.
Shen S; Liu X; Huang J; Sun Y; Liu B; Song W; Meng L; Du M; Feng Q
BMC Oral Health; 2024 May; 24(1):525. PubMed ID: 38702623
[TBL] [Abstract][Full Text] [Related]
58. Quantitative real-time PCR combined with propidium monoazide for the selective quantification of viable periodontal pathogens in an in vitro subgingival biofilm model.
Sánchez MC; Marín MJ; Figuero E; Llama-Palacios A; León R; Blanc V; Herrera D; Sanz M
J Periodontal Res; 2014 Feb; 49(1):20-8. PubMed ID: 23581569
[TBL] [Abstract][Full Text] [Related]
59. An in vitro study of alginate oligomer therapies on oral biofilms.
Roberts JL; Khan S; Emanuel C; Powell LC; Pritchard MF; Onsøyen E; Myrvold R; Thomas DW; Hill KE
J Dent; 2013 Oct; 41(10):892-9. PubMed ID: 23907083
[TBL] [Abstract][Full Text] [Related]
60. α-Amylase is a potential growth inhibitor of Porphyromonas gingivalis, a periodontal pathogenic bacterium.
Ochiai A; Harada K; Hashimoto K; Shibata K; Ishiyama Y; Mitsui T; Tanaka T; Taniguchi M
J Periodontal Res; 2014 Feb; 49(1):62-8. PubMed ID: 23550921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
